Psychostimulant-induced chronic schizophrenia-like disorder

Clinical Schizophrenia and Related Psychoses

Volumn 1, Issue 1, 2007, Pages 54-63

  Pihlgren, Eric M ^a   Boutros, Nash N ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Psychosis; Schizophrenia; Substance Abuse

Indexed keywords

3 METHYLSPIPERONE C 11; AMPHETAMINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; COCAINE; HALOPERIDOL; METHAMPHETAMINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITION; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUCED DISEASE; DRUG INTOXICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; FOLLOW UP; GENETIC PREDISPOSITION; HEROIN DEPENDENCE; HUMAN; NEUROIMAGING; NEUROPSYCHOLOGY; NEUROTOXICITY; NONHUMAN; PARANOID SCHIZOPHRENIA; PSYCHOSIS; PSYCHOSTIMULANT INDUCED PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

EID: 67649703883     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.1.1.4     Document Type: Review

References (79)

1. Lieberman JA, Kinon BJ, Loebel AD. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 1990;16(1): 97-110.
2. Yui K, Goto K, Ikemoto S, Ishiguro T, Angrist B, Duncan GE, Sheitman BB, Lieberman JA, Bracha SH, Ali SF. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Mol Psychiatry 1999;4(6):512-23.
3. Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 2002;4(3):177-84.
4. Tenn CC, Fletcher PJ, Kapur S. A putative animal model of the "prodromal" state of schizophrenia. Biol Psychiatry 2005;57(6):586-93.
5. Angrist BM, Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry 1970;2(2):95-107.
6. Snyder SH. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Am J Psychiatry 1973;130(1):61-7.
7. Harris D, Batki SL. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 2000;9(1):28-37.
8. Serper MR, Chou JC, Allen MH, Czobor P, Cancro R. Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation. Schizophr Bull 1999;25(2):387-94.
9. Shaner A, Roberts LJ, Eckman TA, Racenstein JM, Tucker DE, Tsuang JW, Mintz J. Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatr Serv 1998;49(5):684-90.
10. Sato M, Chen CC, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 1983;18(4):429-40.
11. Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y, Horita N, Kaneko T. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand 1994;89(6):428-32.
12. Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006;188:237-42.
13. Brady KT, Sonne S, Randall CL, Adinoff B, Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend 1995;39(1):69-71.
14. Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology 2003;28(1):34-44.
15. Nakatani Y, Hara T. Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients. Psychopathology 1998; 31(3):131-7.
16. Tatetsu S. Methamphetamine psychosis. Folia Psychiatr Neurol 1963;7(Jpn Suppl):377-80.
17. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006;31(5):301-13.
18. Iyo M, Namba H, Yanagisawa M, Hirai S, Yui N, Fukui S. Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT Prog Neuropsychopharmacol Biol Psychiatry 1997;21(5):789-96.
19. Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 1992;654: 160-70.
20. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Meltzer H, Marsden J, Singleton N, Taylor C. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 2002;181:393-8.
21. Floyd AG, Boutros NN, Struve FA, Wolf E, Oliwa GM. Risk factors for experiencing psychosis during cocaine use: a preliminary report. J Psychiatr Res 2006;40(2):178-82.Epub 2005 Jul 26.
22. Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006;101 Suppl 1:76-88.
23. Connell PH. Amphetamine psychosis. Maudsley monographs no 5. New York: Oxford University Press;1958, p.15-36.
24. Bell DS. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 1965;111:701-7.
25. Ellinwood EH, Jr. Amphetamine psychosis: I. Description of the individuals and process. J Nervous Mental Disease 1967;144:273-83.
26. Charles-Nicolas AJ. [Does chronic psychosis due to amphetamines abuse exist? Study of 25 drug addicts]. Nouv Presse Med 1976; 5(37):2447-50. French.
27. Yui K, Ikemoto S, Ishiguro T, Goto K. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Ann N Y Acad Sci 2000;914:1-12.
28. Utena H. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. Prog Brain Res 1966; 21:192-207.
29. Tomiyama C. Chronic schizophrenia-like states in methamphetamine psychosis. Jpn J Psychiatry Neurol 1990;44(3):531-9.
30. Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol 2003;6(4):347-52.
31. Chen CK, Lin SK, Sham PC, Ball D, Loh el-W, Murry RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet 2005;136(1):87-91.
32. Hayashi, S. [Wake-amine addiction]. Sogorinsyo 1955;12:656-661. Japanese.
33. Goto, T. [Clinical pictures shown by long hospitalized cases of chronic methamphetamine psychosis: a comparative study with schizophrenia]. Psychiatr Neurol Jpn 1960;62:163-76. Japanese.
34. Utena H, Takano S, Yuasa S, Shimizu T, Kato T, Funatogawa S. Behavioral abnormalities in animals and metabolic changes in the brain. No To Shinkei 1961;13:687-95.
35. Askevold F. The occurrence of paranoid incidents and abstinence delirium in abusers of amphetamine. Acta Psychiatr Scand 1959; 34:145-64.
36. Wetli CV, Fishbain DA. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci 1985;30(3):873-80.
37. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004;185:196-204.
38. Gawin FH. Cocaine addiction: psychology and neurophysiology. Science 1991;251(5001):1580-6.
39. Segal DS, Kuczenski R. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav Brain Res 1997;88(2):251-60.
40. Flaum M, Schultz SK. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry 1996;153(6):812-5.
41. Post R. Cocaine psychoses: a continuum model. Am J Psychiatry 1975;132(3):225-31.
42. Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry 1991;148(12):1708-11.
43. Thirthalli J, Benegal V. Psychosis among substance users. Curr Opin Psychiatry 2006;19(3):239-45.
44. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991;48(1):43-51.
45. McLellan AT, Woody CE, O'Brien CP. Development of psychiatric illness in drug abusers: possible role of drug preference. N Eng J Med 1979;301:1310-1314.
46. Rosse RB, Collins JP Jr, Fay-McCarthy M, Alim TN, Wyatt RJ, Deutch SI. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study. Clin Neuropharmacol 1994;17(4):359-69.
47. Rosenthal RN, Miner CR. Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disorders. Schizophr Bull 1997;23(2):187-93.
48. Bartlett E, Hallin A, Chapman B, Angrist B. Selective sensitization to the psychosis inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology 1997;16(1): 77-82.
49. Reid MS, Ciplet D, O'Leary S, Branchey M, Buydens-Branchey L. Sensitization to the psychosis-inducing effects of cocaine compared with measures of cocaine craving and cue reactivity. Am J Addict 2004;13(3):305-15.
50. Unnithan SB, Cutting JC. The cocaine experience: refuting the concept of a model psychosis? Psychopathology 1992;25(2):71-8.
51. Pencer A, Addington J. Substance use and cognition in early psychosis. J Psychiatry Neurosci 2003;28(1):48-54.
52. Iwanami A, Kuroki N, Iritani S, Isono H, Okajima Y, Kamijima K. P3a of event-related potential in chronic methamphetamine dependence. J Nerv Ment Dis 1998;186(12):746-51.
53. Iwanami A, Suga I, Kaneko T, Sugiyama A, Nakatani Y. P300 component of event-related potentials in methamphetamine psychosis and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994;18(3):465-75.
54. Iwanami A, Kanamori R, Suga I, Kaneko T, Kamijima K. Reduced attention-related negative potentials in methamphetamine psychosis. J Nerv Ment Dis 1995;183(11):693-7.
55. Fein G, Biggins C, MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiatry1996;39(11):955-65.
56. Adler LE, Olincy A, Cawthra RN, Hoffer M, Nagamoto HT, Amass L, Freedman R. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology 2001;24(6):671-9.
57. Boutros NN, Gelernter J, Gooding CD, Cubells J, Young A, Krystal JH, Kosten T. Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data. Biol Psychiatry 2002; 51(8):683-6.
58. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. Metaanalysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 2004;70(2-3):315-29.
59. Boutros NN, Lisanby HS, Tokuno H, Torrelo MW, Campbell D, Berman R, Mallison R, Krystal JM, Kosten T. Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. Biol Psychiatry 2001;49(4):369-73.
60. Boutros NN, Lisanby SH, McClain-Furmanski D, Oliwa G, Gooding D, Kosten T. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J Psychiatr Res 2005; 39(3):295-302.
61. Sundaresan K, Ziemann U, Stanley J, Boutros NN. Cortical inhibition and excitation in abstinent cocaine-dependent patients: a transcranial magnetic stimulation study. Neuroreport 2007;18(3):289-92.
62. Wiesbeck GA, Taeschner KL. A cerebral computed tomography study of patients with drug-induced psychoses. Eur Arch Psychiatry Clin Neurosci 1991;241(2):88-90.
63. Iyo M, Nishio M, Itoh T, Fukuda H, Suzuki K, Yamasaki T, Fukui S, Tateno Y. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography. Psychiatry Res 1993;50(4):217-31.
64. Sekine Y, Iyo M, Onouchi Y, Matsunaga T, Tukada H, Okada Y, Yoshikawa E, Mori N. Dopamine transporter in striatum of MAP users using PET. Presented at the 28th Annual Meeting of the Japanese Society of Neuropsychopharmacology;1998 Oct 21-23;Tokyo, Japan.
65. Richtand NM, Woods SC, Berger SP, Strakowski SM. D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev 2001;25(5):427-43.
66. Strakowski SM, Sax KW, Setters MJ, Stanton SP, Keck PE Jr. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans. Biol Psychiatry 1997;42(9):749-55.
67. Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry 2006;63(12):1386-95.
68. Brady KT, Lydiard RB, Malcolm R, Ballenger JC. Cocaine-induced psychosis. J Clin Psychiatry 1991;52(12):509-12.
69. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev 2000;31(2-3):371-84.
70. Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol 2005;25(4):363-6.
71. Green AI, Tohen MF, Hamer RM, Strakowski SM, Lieberman JA, Glick I, Clark WS. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res 2004;66(2-3):125-35.
72. Brown ES, Nejtek VA, Perantie DC, Rajan Thomas N, Rush AJ. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. J Clin Psychopharmacol 2003;23(4):384-8.
73. Broderick PA, Rahni DN, Zhou Y. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. Prog Neuropsychopharmacol Biol Psychiatry 2003;27(6): 1037-54.
74. Srisurapanont M, Kittiratanapaiboon P, Jarusuraisin N. Treatment for amphetamine psychosis. Cochrane Database Syst Rev 2001; (4):CD003026.
75. Meng ZH, Feldpaush DL, Merchant KM. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats. Brain Res Mol Brain Res 1998; 61(1-2):39-50.
76. van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res 2000;45(1-2):11-20.
77. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse 2006;60(4):319-46.
78. Jones PB, Bebbington P, Foerster A, Lewis SW, Murray RM, Russell A, Sham PC, Toone BK, Wilkins S. Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993;162:65-71.
79. Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993;162:80-6.